EUVIMEDEUVIMED entdecken
EditorialOpen Access · CC BY 4.0

Editorial: Epigenomics and metabolomics: pioneering new frontiers in breast cancer research and treatment

Purvi Purohit, Parmod Kumar, Anupama Modi

Frontiers in Oncology · 19.05.2026 · 16

DOI: 10.3389/fonc.2026.1855583 ↗

Kurz gefasst

Editorial in der Zeitschrift Frontiers in Oncology, online erschienen am 19.05.2026. Verfasst von Purvi Purohit und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, All India Institute of Medical Sciences Jodhpur, Jodhpur, India. Die Arbeit nennt 4 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

TME (tumor microenvironment)breast cancerepigenomicsmetabolomicsprecision medicine

Autor:innen und Institutionen

  • Department of Biochemistry, All India Institute of Medical Sciences Jodhpur, Jodhpur, India.
  • Department of Medical Oncology, Gujarat Technological University, Ahmedabad, India.

Zitieren

APA

Purohit, P., Kumar, P., & Modi, A. (2026). Editorial: Epigenomics and metabolomics: pioneering new frontiers in breast cancer research and treatment. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1855583

Vancouver

Purohit P, Kumar P, Modi A. Editorial: Epigenomics and metabolomics: pioneering new frontiers in breast cancer research and treatment. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1855583

BibTeX
@article{Purohit2026,
  author = {Purohit, Purvi and Kumar, Parmod and Modi, Anupama},
  title = {Editorial: Epigenomics and metabolomics: pioneering new frontiers in breast cancer research and treatment},
  journal = {Frontiers in Oncology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fonc.2026.1855583}
}
Kostenlos starten →